CME Group Inc. $CME Shares Purchased by Brevan Howard Capital Management LP

13 Dec 2025, 09:56 by Mitch Edgeman · The Markets Daily

Brevan Howard Capital Management LP grew its holdings in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 62.9% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 174,716 shares of the financial services provider’s stock after purchasing an additional 67,438 shares during the quarter. CME Group makes up about 0.3% of Brevan Howard Capital Management LP’s portfolio, making the stock its 21st biggest holding. Brevan Howard Capital Management LP’s holdings in CME Group were worth $48,155,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. Webster Bank N. A. boosted its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 60 shares during the last quarter. Highline Wealth Partners LLC lifted its stake in CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock worth $26,000 after purchasing an additional 43 shares in the last quarter. Sagard Holdings Management Inc. acquired a new position in shares of CME Group during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC grew its position in shares of CME Group by 59.2% in the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 42 shares in the last quarter. Finally, Ransom Advisory Ltd acquired a new stake in shares of CME Group in the first quarter valued at approximately $31,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at CME Group

In related news, insider Timothy Francis Mccourt sold 379 shares of CME Group stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the transaction, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the sale, the general counsel owned 7,851 shares in the company, valued at approximately $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders sold 2,147 shares of company stock worth $562,079. 0.30% of the stock is owned by company insiders.

Analyst Ratings Changes

CME has been the topic of a number of recent research reports. JPMorgan Chase & Co. boosted their price objective on CME Group from $252.00 to $256.00 and gave the stock an “underweight” rating in a research note on Tuesday, October 14th. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and upped their price objective for the company from $275.00 to $300.00 in a report on Thursday, September 25th. Deutsche Bank Aktiengesellschaft raised their price target on shares of CME Group from $300.00 to $310.00 and gave the stock a “buy” rating in a report on Friday, November 14th. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. Finally, UBS Group reduced their target price on CME Group from $285.00 to $280.00 and set a “neutral” rating on the stock in a research report on Thursday, October 23rd. Eight investment analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $290.00.

Read Our Latest Report on CME Group

CME Group Stock Up 0.4%

Shares of NASDAQ CME opened at $273.55 on Friday. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The business’s 50 day moving average is $271.85 and its two-hundred day moving average is $272.40. CME Group Inc. has a 52-week low of $224.62 and a 52-week high of $290.79. The firm has a market cap of $98.64 billion, a price-to-earnings ratio of 26.51, a PEG ratio of 4.07 and a beta of 0.28.

CME Group (NASDAQ:CME – Get Free Report) last released its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.63 by $0.05. The business had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a return on equity of 14.61% and a net margin of 58.84%.The company’s quarterly revenue was down 3.0% on a year-over-year basis. During the same period last year, the business posted $2.68 earnings per share. Research analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 30th. Stockholders of record on Friday, December 12th will be given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a dividend yield of 1.8%. The ex-dividend date of this dividend is Friday, December 12th. CME Group’s dividend payout ratio is currently 48.45%.

CME Group Profile

(Free Report)